Rutgers University, State University of New York at Stony Brook
Known for
developing first approved HIV integrase inhibitor
Scientific career
Fields
Biology, Biochemistry
Institutions
Merck
Daria J Hazuda is a biochemist known for discovering the first HIV Integrase Strand Transfer Inhibitors (InSTIs) and leading the development of the first HIV integrase inhibitor to gain FDA approval, Isentress (raltegravir).[1] Her lab also determined these inhibitors' mechanism of action and ways the virus could develop resistance to them.[1] Hazuda has also performed extensive research and led the development of antivirals for Hepatitis C Virus (HCV) including Elbasvir and Grazoprevir.[2] She currently serves as Vice President for Infectious Diseases Discovery for Merck and Chief Scientific Officer of their MRL Cambridge Exploratory Science Center.[3]
Daria J Hazuda is a biochemist known for discovering the first HIV Integrase Strand Transfer Inhibitors (InSTIs) and leading the development of the first...
The disease agnostic research site was founded in 2016, and was led by DariaHazuda (Chief Scientific Officer) until 2021. In late 2021 Juan Alvarez took...
Medicine Terry Hart, Class of 1978, astronaut, president of LORAL Skynet DariaHazuda, B.S., biochemist known for discovering the first HIV Integrase Strand...
Siciliano; Anthony Carella; Gwen Carver; Karen Holmes; Renee Danzeisen; DariaHazuda; Joseph Kessler; Janet Lineberger; Michael Miller; William A. Schleif;...
Global Information